Creative Biolabs Advances Anti-Glycan Antibody Discovery for Glycan-Shielded Viruses

Creative Biolabs expands its anti-glycan antibody discovery capabilities, targeting glycan-shielded viruses like Ebola and Zika to support antiviral development.